Not available
ACTRN12619000928112
Treatment
Not Applicable
Hospital,Royal Melbourne Hospital
A/Prof Jonathan Knott
Background Management of dyspepsia in Australian Emergency Departments (ED) typically includes lidocaine viscous and an antacid (pink lady or pink mix). We will investigate whether the addition of either lidocaine viscous or lidocaine solution improves analgesic efficacy, compared to an antacid monotherapy. Methods A double-blind randomised controlled trial will be undertaken in the ED of the Royal Melbourne Hospital, 7 days a week from 0800 to 2300. Patients prescribed a pink lady by the treati .... Read more
• Adult patients 18 years and older. • Patients presenting to the emergency department with acute epigastric pain who are prescribed an antacid / lidocaine mixture.
• Refusal to participate • Those who cannot communicate e.g. dementia, language barriers, or are too ill
No
Sample Size 89
Min. age 18 Years
Max. age No limit
Sex Both males and females
Condition category dyspepsia , gastric pain , indigestion
Condition code Anaesthesiology , Emergency medicine , Oral and Gastrointestinal
Intervention code Treatment: Drugs
10 ml of oral antacid (gastrogel: 500mg AlOH, MgSO3 240mg, MgOH24mg per 500ml) and 10 ml of lidocaine 2% viscous gel given as a one off oral dose together. These will be given as soon as the initial "pink lady" is prescribed by the treating clinician and the allocation has occurred or 10 ml of oral antacid (gastrogel: 500mg AlOH, MgSO3 240mg, MgOH24mg per 500ml) and 10 ml of lidocaine 2% solution given as a one off oral dose together. These will be given as soon as the initial "pink lady" is pre .... Read more
Control group Active
20 ml of oral antacid (gastrogel: 500mg AlOH, MgSO3 240mg, MgOH24mg per 500ml) given as a one off oral dose . This will be given as soon as the initial "pink lady" is prescribed by the treating clinician and the allocation has occurred
Outcome: analgesic efficacy in acute epigastric pain measured by change in visual analogue pain scaleTimepoint: 60 minutes after the medication, a one-off dose, has been administered
yes
all of the individual participant data collected during the trial, after de-identification
Start date: immediately after publication End date: up until 5 years after publication when it is expected that all data will destroyed as per a condition of ethics approval
Anyone from an academic institution who requests it
For any analysis as designed by the requesting academics